- Recent Funding
- Investors
- LifeSci Venture Partners
LifeSci Venture Partners portfolio
LifeSci Venture Partners has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in New York, US, founded in 2017. It led 1 of the 5 rounds it joined. Its most recent investment on record is Ambros Therapeutics's $125M Series A round in December 2025, alongside Transhuman Capital, Adage Capital Management, Balyasny Asset Management and 5 others. By category, its portfolio leans toward Health and bio (3) and Data and analytics (1). It has co-invested with M Ventures, Hikma Ventures and Aphelion Capital, most often M Ventures (3 rounds).
About LifeSci Venture Partners
What LifeSci Venture Partners invests in
- Health and bio · 3 · 100%
- Data and analytics · 1 · 33%
LifeSci Venture Partners recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $125M | Transhuman Capital, Adage Capital Management, Balyasny Asset Management +5 | ||
| Series B+ · $100M | Aphelion Capital, RiverVest, AXA Alternative Investments +5 | ||
| Series B+ · $150M | Third Rock Ventures, Creacion Ventures, Invus +6 | ||
| Series A · $4.75M · lead | Aphelion Capital (lead), JDRF T1D Fund (lead), Hikma Ventures +1 | ||
| Series A · $10M | Three Leaf Ventures, Grey Sky Venture Partners, Hikma Ventures +1 |
How LifeSci Venture Partners invests
LifeSci Venture Partners portfolio companies
AAmbros Therapeutics$125MSeries A · Dec 2025
BBiolinq$100MSeries B+ · Apr 2025
MMOMA Therapeutics$150MSeries B+ · May 2022
| Company | Round with LifeSci Venture Partners | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $125M | $125M | Dec 16, 2025 Series A |
Health and bio |
Series B+ · $100M | $214.75M | Apr 22, 2025 Series B+ |
Health and bio |
Series B+ · $150M | $236M | May 10, 2022 Series B+ |
Most frequent co-investors
MM Ventures3 shared rounds · last Apr 22, 2025
HHikma Ventures3 shared rounds · last Apr 22, 2025
AAphelion Capital2 shared rounds · last Apr 22, 2025
RRA Capital Management1 shared round · last Dec 16, 2025
AArkin Bio Ventures1 shared round · last Dec 16, 2025
JJanus Henderson Investors1 shared round · last Dec 16, 2025
AAdage Capital Management1 shared round · last Dec 16, 2025
TTranshuman Capital1 shared round · last Dec 16, 2025BBalyasny Asset Management1 shared round · last Dec 16, 2025
PPatient Square Capital1 shared round · last Dec 16, 2025
AAbiogen Pharma1 shared round · last Dec 16, 2025
RRiverVest1 shared round · last Apr 22, 2025
Similar investors
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 5 rounds on Recent Funding that name LifeSci Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists LifeSci Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/lifesci-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.